Updates are available Correction dated 2024-11-08
Click to view Correction: https://doi.org/10.1186/s13063-024-08528-5
-
Authors
Hattingh, Laetitia https://orcid.org/0000-0002-4553-743X
Baysari, Melissa T. https://orcid.org/0000-0003-1645-9126
Foot, Holly https://orcid.org/0000-0002-5993-9050
Sim, Tin Fei https://orcid.org/0000-0003-0068-5006
Keijzers, Gerben https://orcid.org/0000-0003-1100-4552
Morgan, Mark https://orcid.org/0000-0001-7749-2427
Scott, Ian https://orcid.org/0000-0002-7596-0837
Norman, Richard https://orcid.org/0000-0002-3112-3893
Yong, Faith https://orcid.org/0000-0002-4878-7565
Mullan, Barbara https://orcid.org/0000-0002-0177-8899
Jackson, Claire https://orcid.org/0000-0003-1177-1380
Oldfield, Leslie E. https://orcid.org/0000-0003-1313-5580
Manias, Elizabeth https://orcid.org/0000-0002-3747-0087
- License Information
-
More Information
Article History
Received: 9 August 2024
Accepted: 23 September 2024
First Online: 27 September 2024
Change Date: 8 November 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s13063-024-08528-5
Declarations
:
: Ethics approval for phases 1 and 2 was obtained from the GCHHS Human Research Ethics Committee on 16 October 2023 (HREC/2023/QGC/101063). Governance and other necessary approvals have been obtained from all sites and universities. Potential participants (e.g. patients, consumers, clinicians, stakeholders) will be provided with an information sheet that explains all the details, benefits and risks of the study. They will be provided an opportunity to ask a research team member questions before signing consent to participate.
: N/A.
: The authors declare that they have no competing interests.
